[Intermediate dose of Ara-C (IDAra-C) for the treatment of refractory and relapsed lymphoid malignancies]

Nihon Gan Chiryo Gakkai Shi. 1988 Jul 20;23(7):1453-8.
[Article in Japanese]
No abstract available

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cytarabine / administration & dosage*
  • Female
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

  • Cytarabine